landscape-field-yellow-meadow.jpg
 

About New Biotic


New Biotic Inc is a clinical stage biotech company in microbiome research. It has researched on gut-brain science since 2008. Research and development is focused on the root causes of central nervous system (CNS) disorders, rather than just symptom management.

The company has developed a potentially game changing treatment for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. It has obtained exciting initial pivotal human data using a microbiome formulation that could be a disease modifying therapeutic for ALS. RaphaLX™ was granted Orphan Drug Designation (ODD) by FDA. 

The company is also in discussion with the FDA about the possible use of its patent pending blood diagnostic biomarker for use in ALS as a companion diagnostic biomarker. Biomarkers for other neurological and psychiatric disorders, including Alzheimer’s, Parkinson’s, MS, schizophrenia, bipolar, etc. are currently being validated. The company holds two provisional patents in diagnostic biomarkers for CNS disorders and a few others in various stages of processing.

Having multiple products in its pipeline New Biotic welcome partners, collaborators and investors to accelerate their product rollout.

 

Management Team

Photo Allen (1).jpg
 

Allen K. Le

Chief Executive Officer

Allen brings a wealth of experience to New Biotic, Inc. spanning over 25 years serving in executive management and senior leadership roles.


He has had several successful startups as the Co-Founder of Mojave Systems, Inc., with over $14 million in funding contracts and, since 2009, the Founder and President of JVT Consulting, Inc. specializing in Medical Products Development. Allen also has been with many mid-sized and large multi-national corporations, such as Unitek Corporation, Perkin-Elmer, and Alcon Laboratories, Inc., across many industries including Healthcare, Medical Devices, Laboratories, Consumer Products, and Aerospace. At JVT Consulting, Inc., Allen was a highly respected Executive Consultant to CEOs/Senior Executives in the areas of Strategic Planning, Profitable Business Model, Product Marketing, Product Development and Regulatory Compliance. He also gained knowledge and experience running and managing a publicly traded company being the Chief Operating Officer, COO, at midiSoft, Inc., later acquired by RecordLab Corporation in Santa Monica, California.

Among his many achievements, Allen holds several US Patents for an Eye Laser Surgical Device and provisional patent for a Physician-Centric Health Care Delivery Platform. Allen graduated from Cal Polytechnic University, Pomona, with a Bachelor of Science degree in Electronics and Computer Engineering.




AngSamPoon1.jpg
 

Sam Ang

Founder & Chief Science Officer

Founder of New Biotic Inc, a microbiome company focusing on therapeutics for CNS disorder.


He started his career as a computer scientist and Artificial Intelligence Researcher in the area of Medical Expert System. While in USC (University Southern California), he built the first medical knowledge base in 1986 for the diagnosis for all known eye diseases. In the past 20 years, Sam has been actively involved in Evidence Based Functional Medicine research for rare diseases with unknown causes, especially in the area of psychiatric and neurodegenerative diseases. His current research areas include

• Role of microbiome as a therapeutic target for ALS ( FDA Orphan Drug Designation)
•Diagnostic Biomarkers for ALS and other neurological and psychiatric conditions and early intervention.




John Tan.jpg
 

John Tan

Chief Strategy Officer

John is a global pharmaceutical executive with 25 years of experience in strategic marketing, commercial transformation, culture integration and organizational capability development. He is the senior Consulting Partner for various Fortune 500 companies and leading Pharmaceutical companies


He was previously the Vice President in Global Marketing and Asia Pacific Strategic Marketing and Sales Director in a multinational health care company. He has led multiple global cross-functional projects and external partnership, and achieved numerous world class product launches. He was also nominated for Global Diversity & Inclusion Leadership award. He holds a Bachelor degree in Pharmacy from Monash University, Australia




Ken_Shearer.jpg

Ken Shearer

VP Product Management

Ken has many years of global experience consistently growing products across a number of small/niche therapeutic areas – from initial strategy development to supporting in-line tactical development.

He has in-market experience in managing and growing products in the hospital market (surgical, anesthesia, and oncology) as well as the biological products therapy areas (auoimmune, congenital empheseyma, hemophilia, hyperimmune, and immune globulin).

Ken has proven experience in succeesful new product launch preparation having launched more than 30 products across large primary care therapy areas to small/niche market ones - globally, within the US, and within Japan.

Ken also is a subject matter expert in Market Research whether functioning as an individual contributor or leading a team of professionals – both globally and in-market.




 
Swu2.jpg

Sean Wu

Chief Financial Officer

Sean is a corporate finance executive with over 15 years of experience building, leading and advising teams through restructurings, international expansion, and capital markets transactions. He has a strong expertise and background in turnaround situations.

Sean is an excellent leader with a track record of contributions leading to improved financial performance, heightened productivity, and enhanced internal controls. The companies he has worked with have ranged from privately held, founder led startups to mature companies, with revenues of $50 million to $2 billion. Sean holds a Bachelor of Science degree in Accounting from the University of Southern California and also has an MBA in Finance from California State University, Fullerton.




 
unnamed.jpg

Dr. William Austin Spruill

Advisory

Dr. Spruill is the Medical Director of the Roanoke Wellness Center. He received a B.A. in Psychology from UNC-Chapel Hill in 1971 and a Ph.D. in Pharmacology from UNC-Chapel Hill in 1977. In 1987 he received his M.D. from East Carolina University. After completing residency training in pediatrics at the University of Virginia, he relocated his family to Roanoke in 1990. He practiced at the Lewis Gale Clinic in Salem, VA until 2000, when he joined Physicians to Children in Roanoke, VA, where he practiced pediatrics until he retired from practice in 2013. He is an active member of the Obesity Medicine Association. He is author of Your Last Diet: A Journey to Wellness.

Dr. Spruill’s interest in family wellness arose from observing a rising incidence of weight-related disorders in children and their parents. He pursued education and training to be able offer wellness services to those families who would benefit from such services.